Efficacy and safety of immune checkpoint inhibitor immunotherapy in elderly cancer patients
Fox, B., de Toro Carmena, M., Álvarez Álvarez, R., Calles Blanco, A., López López, C., Pérez Ramírez, S., Arranz, J. Á., Martín, M., Márquez-Rodas, I.
Published in Clinical & translational oncology (01.04.2020)
Published in Clinical & translational oncology (01.04.2020)
Get full text
Journal Article
1509TiP The 1825-EORTC, ALKALINE: Activity of lorlatinib based on ALK resistance mutations on blood in ALK positive NSCLC patients previously treated with second generation ALK inhibitor
Mezquita, L., Xenophontos, E., Pretzenbaher, Y., Sureda, C., Nadal, E., Al-Rabi, K., Rousseau Bussac, G., Ponce Aix, S., Sullivan, I.G., Calles Blanco, A., Cloarec, N., De Langen, J., Berghmans, T., Descourt, R., Hendriks, L., Garrido Lopez, P., Helland, A., Carcereny, E., Besse, B., Dingemans, A-M.C.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1989MO Lurbinectedin (LUR) in combination with pembrolizumab (PBL) in relapsed small cell lung cancer (SCLC): The phase I/II LUPER study
Blanco, A. Calles, Mendivil, A.F. Navarro, Doger de Spéville, B., Colomé, E. Álvarez, De Miguel Luken, M.J., Alvarez, R.M., Garcia, V. Moreno, J. ramon, Valles, M. Arregui, Corral de la Fuente, E., Alcalá, D., Fernández, M., Morató, J. Rodríguez, Calvo, E., Sanchez, R. Palmero, Jové, M., Felip, E.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1476P Outcomes to first-line pembrolizumab in patients with advanced NSCLC and high PD-L1 expression: A Spanish multicentric study
Piedra, A., Martinez Recio, S., Hernandez Gonzalez, A., Moran Bueno, M.T., Arriola, E., Recuero-Borau, J., Cobo Dols, M., Cordeiro González, P., Mosquera Martinez, J., García-Campelo, M.R., Calles Blanco, A., Alvarez, R.M., Zapata García, M., Isla Casado, M.D., Callejo Perez, A., Iranzo Gomez, P., Barba Joaquín, A., Sullivan, I.G., Felip, E., Majem, M.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1206P UNcommon EGFR mutations: International Case series on efficacy of Osimertinib in Real-life practice in first-liNe setting (UNICORN)
Bar, J., Kian, W., Wolner, M., Derijcke, S., Girard, N., Rottenberg, Y., Dudnik, E., Metro, G., Hochmair, M.J., Aboubakar, F., Cuppens, K., Decoster, L., Reck, M., Limon, D., Blanco, A. Calles, Astaras, C., Häfliger, S., Peled, N., Addeo, A.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Molecular characterization of primary and secondary resistance to RET inhibitors in patients with advanced NSCLC and RET fusions
Marinello, A., Vasseur, D., Conci, N., Lindsay, C., Metro, G., Ferrara, R., Eisert, A., Citarella, F., Fallet, V., Audugier-Valette, C., Cousin, S., Tabbò, F., Russo, A., Calles Blanco, A., Iranzo Gomez, P., Tagliamento, M., Mezquita, L., Ponce, S., Besse, B., Aldea, M.
Published in European journal of cancer (1990) (01.10.2022)
Published in European journal of cancer (1990) (01.10.2022)
Get full text
Journal Article
1007P Mechanisms of primary and secondary resistance to RET inhibitors in patients with RET-positive advanced NSCLC
Marinello, A., Vasseur, D., Conci, N., Fallet, V., Audigier-Valette, C., Cousin, S., Tabbò, F., Guisier, F., Russo, A., Calles Blanco, A., Metro, G., Massa, G., Citarella, F., Eisert, A.K., Iranzo Gomez, P., Tagliamento, M., Mezquita, L., Lindsay, C., Ponce, S., Aldea, M.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
EP1.01-92 Effectiveness of Second-Line Treatment with Nintedanib + Docetaxel (ND) in Patients with Metastatic Lung Adenocarcinoma
Ortega, J.F. Cordoba, Adaniel, C., Morales, S., Gasol, A., Veas, J., Rodriguez, A., Blanco, A. Calles, Salud, A.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
P2.14-29 Clinical Impact of Next-Generation Sequencing (NGS) in Blood Liquid Biopsies for Treatment Decisions in Advanced NSCLC
Pardo, M. Garcia, Delfrade, I. Martinez, Salcedo, I. Aparicio, Valles, M. Arregui, Bianchi, M. Alva, Anula, V. Tirado, Alvarez, R., Blanco, A. Calles
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
EP08.01-048 Spanish Immunotherapy Registry of Cardiovascular Toxicity (SIR-CVT): Preliminary Analysis of the Lung Cancer Cohort
Gutiérrez Sainz, L., Cruz Castellanos, P., Higuera Gómez, O., López Fernández, T., Terol Espinosa de los Monteros, B., Valbuena López, S., Buño, A., Cuesta, E., Del Barco, E., Terán Brage, E., Martín García, A., Eiros Bachiller, R., Sánchez Pablo, C., Martínez Banaclocha, N., Lozano, T., Márquez Rodas, I., Pérez Ramírez, S., Calles Blanco, A., Álvarez, R., Zatarain Nicolás, E., De la Haba Rodríguez, J., Sánchez Mauriño, P., Mesa Rubio, D., Esteban Martínez, F., Martín Fernández, P., Ibáñez Cabeza, B., De Castro Carpeño, J.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
EP08.02-070 High Incidence of Peridiagnosis Thromboembolic Events In Patients with BRAF Mutant Lung Cancer
Aparicio Salcedo, I., Iranzo Gómez, P., Reyes, R., Bote de Cabo, H., Saigi Morgui, M., Bringas Beranek, M., Bosch-Barrera, J., Corral Jaime, J., Aparisi Aparisi, F., Ruffinelli Rodríguez, J.C., Jiménez Munarríz, B., Lage Alfranca, Y., Lopez-Castro, R., Majem Tarruella, M., Vázquez Estevez, S., Artal Cortés, Á., Rodríguez-Pérez, Á.R., Lázaro Quintela, M., Sánchez Torres, J.M., Reguart Aransay, N., Cucurull Salamero, M., Gil-Bazo, I., Camps Herrero, C., Nadal Alforja, E., del Barrio Díaz Aldagalan, A., Garrido López, P., Dómine Gómez, M., Álvarez Álvarez, R., Muñoz Martín, A.J., Calles Blanco, A.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
103P First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC)
Andric, Z.G., Gálffy, G., Dols, M. Cobo, Szima, B., Stojanovic, G., Petrovic, M.D., Font, E. Felip, Baz, D. Vicente, Aix, S. Ponce, Juan-Vidal, O., Tehenes, S., Szalai, Z., Losonczy, G., Blanco, A. Calles, Bernabe, R., Duecker, K., Zhou, D., Schroeder, A., Guezel, G., Ciardiello, F.
Published in Journal of thoracic oncology (01.04.2021)
Published in Journal of thoracic oncology (01.04.2021)
Get full text
Journal Article
Combination of intratumoural double-stranded RNA (dsRNA) BO-112 with systemic anti-PD-1 in patients with anti-PD-1 refractory cancer
Marquez-Rodas, I., Longo, F., Aix, S. Ponce, Jove, M., Rubio, B., Blanco, A. Calles, Rodriguez-Ruiz, M.E., Ponz-Sarvise, M., Castañon, E., Gajate, P., Sempere-Ortega, C., Jimenez-Aguilar, E., Lopez-Casas, P., de Miguel, E., Ramos-Medina, R., Calvo, A., Martin, M., Tersago, D., Quintero, M., Melero, I.
Published in Annals of oncology (01.12.2019)
Published in Annals of oncology (01.12.2019)
Get full text
Journal Article
P2.01-10 Real Clinical Practice Study to Evaluate 2 Line Treatment Based on Comprenhensive Genomic Profiling in NSCLC. LungONE Study
De Castro Carpeno, J., Felip, E., Juan, O., Campelo, R. Garcia, Aguiar, D., Terrassa, J., Castro, R. Lopez, Blanco, A. Calles, Paredes, A., Bernabe, R., Barneto, I., Campillo, J., García-Palacios, L., Rojo, F.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
1509P - Applicability of lung immune prognostic index (LIPI) to predict efficacy of first-line pembrolizumab in advanced non-small cell lung cancer (NSCLC)
Mielgo Rubio, X., Gomez Rueda, A., Antoñanzas, M., Falagan, S., Núñez, J.A., Sánchez Peña, A.M., Gómez-Barreda, I., Martinez Moreno, E., Cerezo Gonzalez, S., Cabezón Gutiérrez, L., Sanchez Torres, J.M., Jimenez Munarriz, B.E., Cervera, R., Pangua Mendez, C., Calles Blanco, A., Lopez Martin, A., López Castro, R., Sotelo Lezama, M.J., Pérez Fernández, E., Cruz, P.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Applicability of lung immune prognostic index (LIPI) to predict efficacy of first-line pembrolizumab in advanced non-small cell lung cancer (NSCLC)
Mielgo Rubio, X., Gomez Rueda, A., Antoñanzas, M., Falagan, S., Núñez, J.A., Sánchez Peña, A.M., Gómez-Barreda, I., Martinez Moreno, E., Cerezo Gonzalez, S., Cabezón Gutiérrez, L., Sanchez Torres, J.M., Jimenez Munarriz, B.E., Cervera, R., Pangua Mendez, C., Calles Blanco, A., Lopez Martin, A., López Castro, R., Sotelo Lezama, M.J., Pérez Fernández, E., Cruz, P.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1262P - Predictive model for survival in advanced non-small cell lung cancer (NSCLC) treated with frontline pembrolizumab
Rubio, X Mielgo, Garcia, M E Olmedo, Moyano, M Sereno, Aguado, C., Núñez, J.A., Gomez, M Domine, Peña, A M Sánchez, Ariza, I Nalda, Gonzalez, S Cerezo, Cabellos, R Alvarez, Gutiérrez, L Cabezón, Mendez, C Pangua, Cervera, R., Blanco, A Calles, Castro, R López, Torres, J M Sanchez, Martin, A Lopez, Ordonez, A Velastegui, Fernández, E Pérez, Cruz, P.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1509PApplicability of lung immune prognostic index (LIPI) to predict efficacy of first-line pembrolizumab in advanced non-small cell lung cancer (NSCLC)
Mielgo Rubio, X, Gomez Rueda, A, Antoñanzas, M, Falagan, S, Núñez, J A, Sánchez Peña, A M, Gómez-Barreda, I, Martinez Moreno, E, Cerezo Gonzalez, S, Cabezón Gutiérrez, L, Sanchez Torres, J M, Jimenez Munarriz, B E, Cervera, R, Pangua Mendez, C, Calles Blanco, A, Lopez Martin, A, López Castro, R, Sotelo Lezama, M J, Pérez Fernández, E, Cruz, P
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1262PPredictive model for survival in advanced non-small cell lung cancer (NSCLC) treated with frontline pembrolizumab
Rubio, X Mielgo, Garcia, M E Olmedo, Moyano, M Sereno, Aguado, C, Núñez, J A, Gomez, M Domine, Peña, A M Sánchez, Ariza, I Nalda, Gonzalez, S Cerezo, Cabellos, R Alvarez, Gutiérrez, L Cabezón, Mendez, C Pangua, Cervera, R, Blanco, A Calles, Castro, R López, Torres, J M Sanchez, Martin, A Lopez, Ordonez, A Velastegui, Fernández, E Pérez, Cruz, P
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Predictive model for survival in advanced non-small cell lung cancer (NSCLC) treated with frontline pembrolizumab
Rubio, X Mielgo, Garcia, M E Olmedo, Moyano, M Sereno, Aguado, C., Núñez, J.A., Gomez, M Domine, Peña, A M Sánchez, Ariza, I Nalda, Gonzalez, S Cerezo, Cabellos, R Alvarez, Gutiérrez, L Cabezón, Mendez, C Pangua, Cervera, R., Blanco, A Calles, Castro, R López, Torres, J M Sanchez, Martin, A Lopez, Ordonez, A Velastegui, Fernández, E Pérez, Cruz, P.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article